Articles published by Biora Therapeutics, Inc.



Via GlobeNewswire
Tickers
BIOR

Biora Therapeutics to Participate in Crohn’s & Colitis Foundation’s IBD Innovate Conference
April 20, 2023
Via GlobeNewswire
Tickers
BIOR



Biora Therapeutics Announces Bioavailability Results for Oral Delivery of GLP-1 Receptor Agonist
February 23, 2023
Via GlobeNewswire
Tickers
BIOR

Biora Therapeutics Announces Improved Bioavailability Results for its Systemic Delivery Platform
February 16, 2023
Via GlobeNewswire
Tickers
BIOR


Biora Therapeutics Receives Pre-IND Feedback from FDA and Provides Update on Key Programs for 2023
January 09, 2023
Via GlobeNewswire
Tickers
BIOR


Biora Therapeutics Announces Two Poster Presentations at the Crohn’s & Colitis Congress
December 08, 2022
Via GlobeNewswire
Tickers
BIOR

Via GlobeNewswire
Tickers
BIOR

Biora Therapeutics Provides Corporate Update and Reports Third Quarter 2022 Financial Results
November 14, 2022
Via GlobeNewswire
Tickers
BIOR

Biora Therapeutics to Report Third Quarter 2022 Financial Results and Provide Corporate Update
November 07, 2022
Via GlobeNewswire
Tickers
BIOR

Biora Therapeutics Announces $9.75 Million Direct Offering
November 07, 2022
Via GlobeNewswire
Tickers
BIOR

Biora Therapeutics Announces Sale of Cell-Free DNA Patent Rights
October 27, 2022
Via GlobeNewswire
Tickers
BIOR

Biora Therapeutics Shares Data from Device Performance Study in Ulcerative Colitis Patients
October 25, 2022
Via GlobeNewswire
Tickers
BIOR



Biora Therapeutics to Participate in 12th Annual Partnership Opportunities in Drug Delivery Conference
October 10, 2022
Via GlobeNewswire
Tickers
BIOR

Via GlobeNewswire
Tickers
BIOR
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.